Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
53,593,532
-
Total 13F shares
-
65,165,847
-
Share change
-
+8,420,099
-
Total reported value
-
$4,403,391,909
-
Put/Call ratio
-
115%
-
Price per share
-
$67.60
-
Number of holders
-
237
-
Value change
-
+$507,196,048
-
Number of buys
-
168
-
Number of sells
-
102
Institutional Holders of Soleno Therapeutics, Inc. - Common Stock (SLNO) as of Q3 2025
As of 30 Sep 2025,
Soleno Therapeutics, Inc. - Common Stock (SLNO) was held by
237 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
65,165,847 shares.
The largest 10 holders included
FMR LLC, JANUS HENDERSON GROUP PLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock, Inc., VANGUARD GROUP INC, Avoro Capital Advisors LLC, WELLINGTON MANAGEMENT GROUP LLP, Vivo Capital, LLC, STATE STREET CORP, and Invesco Ltd..
This page lists
237
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.